TITLE

Disfuncția endotelială, lipodistrofia şi sindromul metabolic la pacienți infectați cu HIV

AUTHOR(S)
PAPIȚĂ, ANAMARIA; ALBU, ADRIANA; ITU, CORINA; CÂRSTINA, D.
PUB. DATE
September 2010
SOURCE
Romanian Journal of Medical Practice;2010, Vol. 5 Issue 3, p185
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
HIV infection has become in our days a chronic disease due to the efficiency of antiretroviral (ARV) treatment. Soon after the introduction of this treatment its complications related to metabolic disturbances have been observed and studied. Metabolic syndrome was particularly described in relation with the administration of protease inhibitors (PI), as well as lipohypertrophy, an entity described in the context of the lipodystrophic syndrome. It is known that disturbances of lipid metabolism precede and accompany usually endothelial dysfunction. Also, different studies showed an association of metabolic syndrome in patients with lipodystrophy. Though, these manifestations are strongly correlated and seem to be implicated in the increased cardiovascularv risck observed in these patients. Our paper presents a synthesis of some recent data on lipodystrophy, metabolic syndrome and their relation to endothelial dysfunction in HIV infected patients.
ACCESSION #
55574784

 

Related Articles

  • Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients.  // BMC Infectious Diseases;2011, Vol. 11 Issue 1, p246 

    The article presents information on a study conducted to evaluate the prevalence of metabolic syndrome (MS) in HIV-infected patients, and to determine whether patients with or without clinical lipodystrophy (CL) had a different prevalence of metabolic abnormalities (MA). The study concluded that...

  • Contribution of Inflammation to Fat Redistribution and Metabolic Disturbances in HIV-1 Infected Patients. Stankov, Metodi V.; Behrens, Georg M. N. // Current Pharmaceutical Design;10/11/2010, Vol. 16 Issue 30, p3361 

    No abstract available.

  • Effects of Lipodystrophy on Quality of Life and Depression in HIV-Infected Men on HAART. Steel, J. L.; Landsittel, D.; Calhoun, B.; Wieand, S.; Kingsley, L. A. // AIDS Patient Care & STDs;Aug2006, Vol. 20 Issue 8, p565 

    The aim of the study was a prospective assessment of the possible consequences of a diagnosis of lipodystrophy on health-related quality of life (HRQL) and depressive symptomatology in HIV-seropositive men who have sex with men. A standardized physical assessment for lipodystrophy was introduced...

  • Self-reported signs of lipodystrophy by persons living with HIV infection. Dreezen, C.; Schrooten, W.; De Mey, I.; Goebel, F. D.; Dedes, N.; Florence, E.; Colebunders, R.; Eurosupport Study Group // International Journal of STD & AIDS;Jun2002, Vol. 13 Issue 6, p393 

    Objective: To identify risk factors for the development of lipodystrophy in HIV infected patients on highly active antiretroviral therapy.Methods: A survey among patients with HIV infection using an anonymous questionnaire was conducted in 10 European countries between...

  • Antiretrovirals.  // Reactions Weekly;1/22/2011, Issue 1335, p8 

    The article describes the case of three patients who acquired HIV-associated lipodystrophy while undergoing antiretroviral therapy.

  • Characteristics Associated to Lipodystrophy Syndrome among HIV-Infected Patients Naive and on Antiretroviral Treatment. Alencastro, Paulo R.; Wolff, Fernando H.; Schuelter-Trevisol, Fabiana; Ikeda, Maria Letícia; Brandão, Ajácio B. M.; Barcellos, Nemora T.; Fuchs, Sandra C. // Journal of AIDS & Clinical Research;2012, Vol. 3 Issue 9, Special section p1 

    Background: HIV-associated lipodystrophy involves changes in complex metabolic networks that are associated with increased cardiovascular risk. It has been associated with the use of combined antiretroviral treatment (cART), particularly Protease Inhibitors (PI) and thymidine analogs. This study...

  • Pharmacogenetics of the Metabolic Disturbances and Atherosclerosis Associated with Antiretroviral Therapy in HIV-Infected Patients. Veloso, Sergi; Peraire, Joaquim; Viladés, Consuelo; López-Dupla, Miguel; Escoté, Xavier; Olona, Montserrat; Garcia-Pardo, Graciano; Gómez-Bertomeu, Frederic; Soriano, Antoni; Sirvent, Joan-Josep; Vidal, Francesc // Current Pharmaceutical Design;10/11/2010, Vol. 16 Issue 30, p3379 

    No abstract available.

  • Lipoatrophy Is the Predominant Presentation of HIV-Associated Lipodystrophy in Southern India.  // Clinical Infectious Diseases;6/1/2004, Vol. 38 Issue 11, p1646 

    At Yrg Care, a nonprofit organization and tertiary referral care center in southern India that provides medical and psychosocial care for nearly 4000 people living with HIV infection, all patients receiving antiretroviral therapy (ART) have had anthropometric measurements taken at each clinic...

  • Lipodystrophy Severity Does Not Contribute to HAART Nonadherence. Collins, Evan J.; Burgoyne, Robert W.; Wagner, Cheryl A.; Abbey, Susan E.; Halman, Mark H.; Nur, Margaret L.; Walmsley, Sharon L. // AIDS & Behavior;May2006, Vol. 10 Issue 3, p273 

    Lipodystrophy severity among 77 people living with HIV/AIDS (PHA) with body fat redistribution was not related to antiretroviral adherence including doses missed during the previous month, categorical rating of maximal adherence, and the PMAQ7 adherence behavior scale. Two thirds of the sample...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics